MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
34.50
+0.51
+1.50%
After Hours: 34.50 0 0.00% 16:15 11/12 EST
OPEN
33.64
PREV CLOSE
33.99
HIGH
34.68
LOW
32.76
VOLUME
440.80K
TURNOVER
--
52 WEEK HIGH
44.28
52 WEEK LOW
17.72
MARKET CAP
1.06B
P/E (TTM)
-44.9804
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture
PR Newswire · 12h ago
Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference
PR Newswire · 1d ago
DecisionDx®-Melanoma Data at SDPA and Dermato-Onco2026 Support the Test's Ability to Refine Risk Assessment Beyond AJCC Staging
PR Newswire · 1d ago
Guggenheim Remains a Buy on Castle Biosciences (CSTL)
TipRanks · 2d ago
Castle Biosciences Price Target Raised to $52.00/Share From $44.00 by BTIG
Dow Jones · 2d ago
Castle Biosciences Is Maintained at Buy by BTIG
Dow Jones · 2d ago
Castle Biosciences price target raised to $52 from $44 at BTIG
TipRanks · 3d ago
Castle Biosciences Price Target Raised to $41.00/Share From $39.00 by Baird
Dow Jones · 3d ago
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers around six commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology ophthalmology and includes a test to guide systemic treatment decisions in patients with moderate-to-severe AD. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for patients with cutaneous squamous cell carcinoma (SCC).

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.